Stephen A. Sherwin, M.D.

Stephen A. Sherwin, M.D.

DirectoratNeurocrine Biosciences· In the 2022 proxy

Stephen A. Sherwin, M.D. sits on 4 public boards.

Boards1

  • Neurocrine BiosciencesDirector · 3 yr on the boardIndependentAudit, Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Neurocrine BiosciencesPublic company · 4 yr
    • Director2022 – Present · 4 yrStock in role +72%
  2. BioPlus Special Purpose Acquisition CorporationPublic company
    • Director? – PresentNo stock prices for these years
  3. BiogenPublic company
    • Director? – PresentNo stock prices for these years
  4. Neon TherapeuticsPublic company · 13 yr
    • Director2001 – 2014 · 13 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?